(Reuters) - Canadian medical marijuana maker Aurora Cannabis Inc has won the rights to negotiate a licensing deal with CannaRoyalty Corp that will allow it to sell a range of cannabis-infused consumer products.
Aurora—one of the biggest Canadian cannabis companies—has an exclusive right for 90 days to hammer out a licensing agreement that could give it the rights to sell inhalers, transdermal patches, gels and lotions.
RELATED: Canadian Cannabis News
Aurora, which currently only makes medical cannabis, has been seeking deals to offer more products including consumer-oriented products like ones offered by CannaRoyalty, a small Ottawa-based firm.
